Latest NewsNewsTFT News

5,000 fans joined Indochine’s COVID-19 trial gig in Paris

Photo for illustrative purposes only.

Around 5,000 fans of French rock band Indochine participated in a COVID-19 research to see their favorite band live for the first time since the pandemic began.

The concert goers took part in the experimental event at Paris’s Bercy concert hall on Saturday.

According to an AFP report, a further 2,500 volunteers who did not attend the concert will be used as a comparison group.

RELATED STORY: LOOK: 5,000 people attend concert in Barcelona after COVID-19 test

The trial, organised by AP-HP (Assistance publique-Hopitaux de Paris) and Prodiss, the national union for musical and variety shows, aims to assess the risk of COVID-19 transmission at live events.

The live music and entertainment sector, which has severely impacted by pandemic, ate awaiting for the reopening of concert venues to live audiences.

Prior to admission, the concert goers, all aged between 18 and 45 without comorbidities, handed over an envelope containing a saliva test done earlier on Saturday.

They were all required to provide a negative antigen test result in the last three days.

Social distancing was not required but masks were compulsory during the concert.

READ ON: Concerts, weddings, to resume; maximum of 10 per table at restaurants, as Dubai eases precautionary measures

The concert began earlier with Indochine on stage by 6pm due to curfew imposed by French authorities.

Similar trials have already conducted in Spain and Britain while the Bercy concert had been postponed a number of times.

The trial has finally pushed through two days ahead of the France’s rollout of its COVID-19 inoculation program to all adults.

Results from the concertgoers study are expected by late June. (RA)

Staff Report

The Filipino Times is the chronicler of stories for, of and by Filipinos all over the world, reaching more than 236 countries in readership. Any interesting story to share? Email us at [email protected]

Related Articles

Back to top button